Medication-info.com Search Menu

EYsuVIS (Loteprednol etabonate): Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
2.5 mg/mL
Other brand names:
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - EYsuVIS

Before you use EYSUVIS for the first time:

There are two caps on your bottle of EYSUVIS. Hold the bottle firmly by its neck. Remove the white cap by twisting it clockwise (See Figure A). Throw away the white cap. EYSUVIS is now ready to use.

Figure A

Follow Steps 1 to 6 each time you use EYSUVIS.

  1. 1. Wash your hands well.
  2. 2.

    Shake the EYSUVIS bottle for 2 to 3 seconds before using (See Figure B).

    Figure B

  3. 3.

    Remove the pink cap from the top of the EYSUVIS dropper by turning it counterclockwise (See Figure C). Keep the pink cap. Do not let the EYSUVIS dropper tip touch your eye, fingers, or any other surface.

    Figure C

  4. 4.

    Turn the EYSUVIS bottle upside down (See Figure D).

    Figure D

  5. 5.

    Tilt your head back. Hold the bottle directly above your affected eye. Squeeze the middle of the EYSUVIS bottle gently to put 1 to 2 drops (follow your doctor's instruction) into the affected eye (See Figure E).

    Figure E

  6. 6.

    Place the pink cap back onto the EYSUVIS bottle and tighten by turning clockwise (See Figure F).

    Figure F

If you use contact lenses, wait for 15 minutes before placing them back in.

How should I store EYSUVIS?

  • Store EYSUVIS upright between 59ºF to 77ºF (15ºC to 25ºC).
  • Do not freeze.
  • After opening, EYSUVIS can be used until the expiration date (EXP) on the bottle. The expiration date can be found on the lower right side of the label on the bottle.

Keep EYSUVIS and all medicines out of the reach of children.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Manufactured for:

Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA

Approved 11/2023

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 210933 · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for EYsuVIS

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Corticosteroid
Active ingredient Loteprednol etabonate 2.5 mg/mL
Dosage form Suspension/ drops
Route Ophthalmic
Marketing status listed in the FDA NDC Directory
Company (applicant) ALCON LABS INC
FDA approval NDA 210933New Drug Application (NDA) Approved October 26, 2020
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
2.5 mg/mL – 8.3 ml in 1 bottle, dropper / 1 in 1 carton NDC 71571-333-83
2.5 mg/mL – 2.4 ml in 1 bottle, dropper NDC 71571-333-24
2.5 mg/mL – 1 ml in 1 bottle, dropper / 1 in 1 carton

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.